Literature DB >> 19065653

Cancer patterns in nasopharyngeal carcinoma multiplex families in Taiwan.

Kelly J Yu1, Wan-Lun Hsu, Chun-Ju Chiang, Yu-Juen Cheng, Ruth M Pfeiffer, Scott R Diehl, Alisa M Goldstein, Patti E Gravitt, Chien-Jen Chen, Allan Hildesheim.   

Abstract

Genetic and environmental factors have been implicated in the etiology of nasopharyngeal carcinoma (NPC), a tumor known to be closely associated with Epstein-Barr virus (EBV) infection. Studies have reported familial aggregation of NPC and have suggested the possible aggregation of NPC and other cancers. We evaluated familial aggregation of cancer in 358 high-risk families with two or more NPC cases enrolled in a NPC genetics study in Taiwan. Participants were linked to the Taiwan National Cancer Registry to identify incident cancers diagnosed after study enrollment (started in 1996) and before December 31, 2005, or death. In total, 2,870 individuals from the NPC Multiplex Family Study contributed 15,151 person-years over an average of 5.3 years of follow-up. One hundred ten incident cancers were identified. Multiple-primary standardized incidence ratios (MP-SIRs) were computed to evaluate overall cancer risk associated with infectious agents and with other tumors. The overall MP-SIR was 1.3 (95% CI: 1.1-1.6), which was largely explained by an excess in NPC (MP-SIR = 15; 95% CI: 10-23). Exclusion of incident NPC diagnoses led to an overall MP-SIR of 1.0 (95% CI: 0.83-1.3). Similarly, the observed excess risk of cancers associated with infectious agents (MP-SIR = 2.0; 95% CI: 1.5-2.6) was driven by the excess in NPC; exclusion of NPC cases led to a reduced MP-SIR that did not differ from 1.0. Analysis of the largest NPC multiplex family study to date confirms the presence of coaggregation of NPC within families in Taiwan but does not provide evidence for a broader familial syndrome involving NPC and other tumors.

Entities:  

Mesh:

Year:  2009        PMID: 19065653      PMCID: PMC2796215          DOI: 10.1002/ijc.24051

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan.

Authors:  A Hildesheim; L M Anderson; C J Chen; Y J Cheng; L A Brinton; A K Daly; C D Reed; I H Chen; N E Caporaso; M M Hsu; J Y Chen; J R Idle; R N Hoover; C S Yang; S K Chhabra
Journal:  J Natl Cancer Inst       Date:  1997-08-20       Impact factor: 13.506

2.  Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan.

Authors:  Allan Hildesheim; Raymond J Apple; Chien-Jen Chen; Sophia S Wang; Yu-Juen Cheng; William Klitz; Steven J Mack; I-How Chen; Mow-Ming Hsu; Czau-Siung Yang; Louise A Brinton; Paul H Levine; Henry A Erlich
Journal:  J Natl Cancer Inst       Date:  2002-12-04       Impact factor: 13.506

Review 3.  The aetiology of nasopharyngeal carcinoma.

Authors:  A L McDermott; S N Dutt; J C Watkinson
Journal:  Clin Otolaryngol Allied Sci       Date:  2001-04

4.  Second malignant tumors in patients with nasopharyngeal carcinoma and their association with Epstein-Barr virus.

Authors:  C C Wang; M L Chen; K H Hsu; S P Lee; T C Chen; Y S Chang; N M Tsang; J H Hong
Journal:  Int J Cancer       Date:  2000-07-15       Impact factor: 7.396

5.  Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries.

Authors:  Ghislaine Scélo; Paolo Boffetta; Marilys Corbex; Kee-Seng Chia; Kari Hemminki; Soren Friis; Eero Pukkala; Elisabete Weiderpass; Mary L McBride; Elizabeth Tracey; David H Brewster; Vera Pompe-Kirn; Erich V Kliewer; Jon M Tonita; Carmen Martos; Jon G Jonasson; Paul Brennan
Journal:  Cancer Causes Control       Date:  2007-01-19       Impact factor: 2.506

6.  Familial aggregation of nasopharyngeal carcinoma and other malignancies. A clinicopathologic description.

Authors:  C M Coffin; S S Rich; L P Dehner
Journal:  Cancer       Date:  1991-09-15       Impact factor: 6.860

7.  Epstein-Barr virus seroreactivity among unaffected individuals within high-risk nasopharyngeal carcinoma families in Taiwan.

Authors:  Amy Pickard; Chien-Jen Chen; Scott R Diehl; Mei-Ying Liu; Yu-Juen Cheng; Wan-Lun Hsu; Brenda Sun; Mow-Ming Hsu; I-How Chen; Jen-Yang Chen; Czau-Siung Yang; Beth L Mittl; Sheng-Ping Chou; Deborah D Ruggles; Alisa M Goldstein; Allan Hildesheim
Journal:  Int J Cancer       Date:  2004-08-10       Impact factor: 7.396

8.  Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4.

Authors:  Bing-Jian Feng; Wei Huang; Yin Yao Shugart; Ming K Lee; Feng Zhang; Jian-Chuan Xia; Hui-Yun Wang; Teng-Bo Huang; Shao-Wen Jian; Ping Huang; Qi-Sheng Feng; Li-Xi Huang; Xing-Juan Yu; Duang Li; Li-Zheng Chen; Wei-Hua Jia; Yan Fang; Hui-Ming Huang; Jing-Liu Zhu; Xiao-Ming Liu; Yan Zhao; Wang-Qing Liu; Mang-Quan Deng; Wei-Han Hu; Shao-Xiong Wu; Hao-Yuan Mo; Ming-Fang Hong; Mary Claire King; Zhu Chen; Yi-Xin Zeng
Journal:  Nat Genet       Date:  2002-07-15       Impact factor: 38.330

9.  Human leukocyte antigen (HLA) frequency among patients with nasopharyngeal carcinoma in Taiwan.

Authors:  S B Wu; S J Hwang; A S Chang; T Hsieh; M M Hsu; R P Hsieh; C J Chen
Journal:  Anticancer Res       Date:  1989 Nov-Dec       Impact factor: 2.480

10.  A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma.

Authors:  Wei Xiong; Zhao Yang Zeng; Jia Hui Xia; Kun Xia; Shou Rong Shen; Xiao Ling Li; Dong Xu Hu; Chen Tan; Juan Juan Xiang; Jie Zhou; Hao Deng; Song Qing Fan; Wei Fang Li; Rong Wang; Ming Zhou; Shi Guo Zhu; Hong Bin Lü; Jun Qian; Bi Cheng Zhang; Jie Ru Wang; Jian Ma; Bing Yi Xiao; He Huang; Qiu Hong Zhang; Yan Hong Zhou; Xiao Min Luo; Hou De Zhou; Yi Xin Yang; He Ping Dai; Guo Yin Feng; Qian Pan; Ling Qian Wu; Lin He; Gui Yuan Li
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

View more
  13 in total

1.  Epstein-Barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in Taiwan.

Authors:  Anna E Coghill; Wan-Lun Hsu; Ruth M Pfeiffer; Hedy Juwana; Kelly J Yu; Pei-Jen Lou; Cheng-Ping Wang; Jen-Yang Chen; Chien-Jen Chen; Jaap M Middeldorp; Allan Hildesheim
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-04-27       Impact factor: 4.254

2.  Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families.

Authors:  Kelly J Yu; Wan-Lun Hsu; Ruth M Pfeiffer; Chun-Ju Chiang; Cheng-Ping Wang; Pei-Jen Lou; Yu-Juen Cheng; Patti Gravitt; Scott R Diehl; Alisa M Goldstein; Chien-Jen Chen; Allan Hildesheim
Journal:  Clin Cancer Res       Date:  2011-03-29       Impact factor: 12.531

3.  Familial nasopharyngeal carcinomas possess distinguished clinical characteristics in southern China.

Authors:  Su-Mei Cao; Sui-Hong Chen; Chao-Nan Qian; Qing Liu; Yun-Fei Xia
Journal:  Chin J Cancer Res       Date:  2014-10       Impact factor: 5.087

4.  WTC-01, a novel synthetic oxime-flavone compound, destabilizes microtubules in human nasopharyngeal carcinoma cells in vitro and in vivo.

Authors:  Chang-Ying Chiang; Tai-Chi Wang; Choa-Hsun Lee; Chien-Shu Chen; Shih-Hao Wang; Yu-Chin Lin; Shin-Hun Juang
Journal:  Br J Pharmacol       Date:  2015-08-14       Impact factor: 8.739

5.  Quantification of familial risk of nasopharyngeal carcinoma in a high-incidence area.

Authors:  Zhiwei Liu; Ellen T Chang; Qing Liu; Yonglin Cai; Zhe Zhang; Guomin Chen; Qi-Hong Huang; Shang-Hang Xie; Su-Mei Cao; Jian-Yong Shao; Wei-Hua Jia; Yuming Zheng; Jian Liao; Yufeng Chen; Longde Lin; Liming Liang; Ingemar Ernberg; Thomas L Vaughan; Hans-Olov Adami; Guangwu Huang; Yi Zeng; Yi-Xin Zeng; Weimin Ye
Journal:  Cancer       Date:  2017-02-27       Impact factor: 6.860

6.  Epstein-Barr Virus-Based Nasopharyngeal Carcinoma (NPC) Risk Prediction Scores Are Elevated in NPC Multiplex Family Members in Taiwan.

Authors:  Mei-Hsuan Lee; Yu-Han Huang; Anna E Coghill; Zhiwei Liu; Kelly J Yu; Wan-Lun Hsu; Yin-Chu Chien; Cheng-Ping Wang; Tseng-Cheng Chen; Chien-Jen Chen; Allan Hildesheim
Journal:  J Infect Dis       Date:  2021-02-13       Impact factor: 5.226

7.  Integrated genomic analysis suggests MLL3 is a novel candidate susceptibility gene for familial nasopharyngeal carcinoma.

Authors:  Mark M Sasaki; Andrew D Skol; Riyue Bao; Lindsay V Rhodes; Rachelle Chambers; Everett E Vokes; Ezra E W Cohen; Kenan Onel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-05-26       Impact factor: 4.254

8.  Invited commentary: Epstein-Barr virus-based screening for the early detection of nasopharyngeal carcinoma: a new frontier.

Authors:  Allan Hildesheim
Journal:  Am J Epidemiol       Date:  2012-12-19       Impact factor: 4.897

9.  Characterization of ELISA detection of broad-spectrum anti-Epstein-Barr virus antibodies associated with nasopharyngeal carcinoma.

Authors:  Cindy Chang; Jaap Middeldorp; Kelly J Yu; Hedy Juwana; Wan-Lun Hsu; Pei-Jen Lou; Cheng-Ping Wang; Jen-Yang Chen; Mei-Ying Liu; Ruth M Pfeiffer; Chien-Jen Chen; Allan Hildesheim
Journal:  J Med Virol       Date:  2012-12-21       Impact factor: 2.327

10.  Correlates of anti-EBV EBNA1 IgA positivity among unaffected relatives from nasopharyngeal carcinoma multiplex families.

Authors:  C M Chang; K J Yu; W L Hsu; J M Major; J Y Chen; P J Lou; M Y Liu; S R Diehl; A M Goldstein; C J Chen; A Hildesheim
Journal:  Br J Cancer       Date:  2011-11-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.